COMPASS Pathways plc (CMPS) stock
CMPSNasdaqPharmaceutical PreparationsFiscal year ends December 31
$9.01−0.11 (-1.21%)
Close on Nov 13, 2026Market cap $1.25BP/E –Yield –
COMPASS Pathways cash
Cash and short-term investments held at the end of each period.
COMPASS Pathways's cash was $433.30M at Jun 30, 2026. For fiscal 2025 it was $149.61M, down 9.6% from the year before. The highest annual figure on record is $273.24M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $149.61M | -9.6% |
| FY2024 | Dec 31, 2024 | $165.47M | -25.0% |
| FY2023 | Dec 31, 2023 | $220.64M | +53.9% |
| FY2022 | Dec 31, 2022 | $143.38M | -47.5% |
| FY2021 | Dec 31, 2021 | $273.24M | +43.5% |
| FY2020 | Dec 31, 2020 | $190.36M | +661.9% |
| FY2019 | Dec 31, 2019 | $24.98M | +9.1% |
| FY2018 | Dec 31, 2018 | $22.91M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $433.30M | +95.3% |
| Q1 FY2026 | Mar 31, 2026 | $466.01M | +79.2% |
| Q4 FY2025 | Dec 31, 2025 | $149.61M | -9.6% |
| Q3 FY2025 | Sep 30, 2025 | $185.94M | -10.2% |
| Q2 FY2025 | Jun 30, 2025 | $221.88M | -3.0% |
| Q1 FY2025 | Mar 31, 2025 | $260.11M | -1.1% |
| Q4 FY2024 | Dec 31, 2024 | $165.47M | -25.0% |
| Q3 FY2024 | Sep 30, 2024 | $206.95M | -16.6% |
| Q2 FY2024 | Jun 30, 2024 | $228.63M | +54.2% |
| Q1 FY2024 | Mar 31, 2024 | $262.89M | +124.5% |
| Q4 FY2023 | Dec 31, 2023 | $220.64M | +53.9% |
| Q3 FY2023 | Sep 30, 2023 | $248.04M | +43.3% |
| Q2 FY2023 | Jun 30, 2023 | $148.23M | -28.5% |
| Q1 FY2023 | Mar 31, 2023 | $117.10M | -51.9% |
| Q4 FY2022 | Dec 31, 2022 | $143.38M | -47.5% |
| Q3 FY2022 | Sep 30, 2022 | $173.08M | -41.1% |
| Q2 FY2022 | Jun 30, 2022 | $207.18M | -34.5% |
| Q1 FY2022 | Mar 31, 2022 | $243.68M | +35.7% |
| Q4 FY2021 | Dec 31, 2021 | $273.24M | +43.5% |
| Q3 FY2021 | Sep 30, 2021 | $293.96M | +49.6% |
| Q2 FY2021 | Jun 30, 2021 | $316.33M | +367.9% |
| Q1 FY2021 | Mar 31, 2021 | $179.52M | +618.5% |
| Q4 FY2020 | Dec 31, 2020 | $190.36M | +731.0% |
| Q3 FY2020 | Sep 30, 2020 | $196.51M | – |
| Q2 FY2020 | Jun 30, 2020 | $67.61M | – |
| Q4 FY2019 | Dec 31, 2019 | $24.98M | – |
| Q4 FY2018 | Dec 31, 2018 | $22.91M | – |
See a number that looks wrong?